2.50
Hdl Handle:
http://hdl.handle.net/2336/15438
Title:
Is opportunistic disease prevention in the consultation ethically justifiable?
Authors:
Getz, Linn; Sigurdsson, Johann A; Hetlevik, Irene
Citation:
BMJ 2003, 327(7413):498-500
Issue Date:
30-Aug-2003
Abstract:
Medical resources are increasingly shifting from making patients better to preventing them from becoming ill. Genetic testing is likely to extend the list of conditions that can be screened for. Is it time to stop and consider whom we screen and how we approach it?
Description:
To access publisher version of this article. Please click on the hyperlink in Additional Links field; To access full text version of this article. Please click on the hyperlink "View/Open" at the bottom of this page
Additional Links:
http://dx.doi.org/10.1136/bmj.327.7413.498.

Full metadata record

DC FieldValue Language
dc.contributor.authorGetz, Linn-
dc.contributor.authorSigurdsson, Johann A-
dc.contributor.authorHetlevik, Irene-
dc.date.accessioned2007-12-20T09:52:23Z-
dc.date.available2007-12-20T09:52:23Z-
dc.date.issued2003-08-30-
dc.date.submitted2007-12-20-
dc.identifier.citationBMJ 2003, 327(7413):498-500en
dc.identifier.issn0959-8138-
dc.identifier.pmid12946974-
dc.identifier.doi10.1136/bmj.327.7413.498-
dc.identifier.urihttp://hdl.handle.net/2336/15438-
dc.descriptionTo access publisher version of this article. Please click on the hyperlink in Additional Links fielden
dc.descriptionTo access full text version of this article. Please click on the hyperlink "View/Open" at the bottom of this pageen
dc.description.abstractMedical resources are increasingly shifting from making patients better to preventing them from becoming ill. Genetic testing is likely to extend the list of conditions that can be screened for. Is it time to stop and consider whom we screen and how we approach it?en
dc.language.isoenen
dc.publisherBritish Medical Associationen
dc.relation.urlhttp://dx.doi.org/10.1136/bmj.327.7413.498.en
dc.subject.meshGuideline Adherenceen
dc.subject.meshHumansen
dc.subject.meshMass Screeningen
dc.subject.meshPatient Advocacyen
dc.subject.meshPractice Guidelines as Topicen
dc.subject.meshPreventive Medicineen
dc.subject.meshPrimary Health Careen
dc.subject.meshRisk Factorsen
dc.titleIs opportunistic disease prevention in the consultation ethically justifiable?en
dc.typeArticleen
dc.identifier.eissn1468-5833-
dc.identifier.journalBMJ (Clinical research ed.)en

Related articles on PubMed

All Items in Hirsla are protected by copyright, with all rights reserved, unless otherwise indicated.